期刊文献+

419例药物性肝损伤患者临床特点与自身抗体特征分析 被引量:1

Clinical features and autoantibody characteristics of patients with drug-induced liver injury:An analysis of 419 cases
下载PDF
导出
摘要 目的研究药物性肝损伤(DILI)患者的临床特点与自身抗体特征。方法回顾性分析2014年9月—2018年9月首都医科大学附属北京地坛医院收治的肝功能异常且通过RUCAM评分临床诊断为DILI的患者,收集入院时的基线肝功能、肾功能、血常规、免疫五项、自身抗体、肝穿刺活检结果。计量资料满足正态性2组间比较使用t检验;计量资料不满足正态性2组间比较使用Mann-Whitney U检验。采用卡方检验研究不同性别、肝损伤类型之间的自身抗体检出率是否存在差异;用logistic回归方法分析自身抗体与性别、年龄、损伤类型之间是否存在回归关系;以各项基线化验结果做自变量,ANA的滴度分级作为因变量做有序logistic回归分析。结果共入组419例DILI患者,中位年龄47(35~55)岁,其中男性占32.5%(136/419),女性占67.5%(283/419);肝细胞型有88例(21.5%),混合型87例(21.2%),胆汁淤积型235例(57.3%)。自身抗体检出率为50.6%(212/419),其中抗核抗体检出率为42.9%(180/419),抗体滴度以1∶100为主(104/180)。不同性别(χ^(2)=2.658,P=0.103)与不同损伤类型(χ^(2)=0.859,P=0.651)之间的自身抗体检出率差异均无统计学意义。二元logistics回归提示性别、年龄和损伤类型与自身抗体之间均不存在回归关系(P值均>0.05)。自身抗体阳性组和阴性组患者的PTA和INR存在显著差异(t=2.161,P=0.031;Z=-3.010,P=0.003)。有序logistics回归提示INR和IgG与ANA分级有相关性(OR=3.101,P=0.040;OR=1.043,P=0.014)。结论DILI患者自身抗体检出率较高,但自身抗体检出率与性别、损伤类型、年龄无关,自身抗体阳性与阴性患者之间的PTA和INR存在差异,INR和IgG水平与ANA抗体滴度有相关性。 Objective To investigate the clinical features and autoantibody characteristics of patients with drug-induced liver injury(DILI).Methods A retrospective analysis was performed for the patients with abnormal liver function who were admitted to Beijing Ditan Hospital,Capital Medical University,from September 2014 to September 2018 and were diagnosed with DILI based on RUCAM score,and related data on admission were collected,including baseline liver function,renal function,routine blood test results,five immune indices,autoantibody,and liver biopsy results.The t-test was used for comparison of normally distributed continuous data between two groups,and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups;the chi-square test was used to compare the detection rate of autoantibody between the patients with different sexes or types of liver injury.A logistic regression analysis was used to investigate whether autoantibody had a regression relationship with sex,age,and type of injury,and an ordinal logistic regression analysis was performed with baseline laboratory results as independent variables and anti-nuclear antibody(ANA)titer as the dependent variable.Results A total of 419 patients with DILI were enrolled in the study,with a median age of 47(35-55)years,among whom male patients accounted for 32.5%(136/419)and female patients accounted for 67.5%(283/419).Among these 419 patients,88(21.5%)had hepatocellular-type liver injury,87(21.2%)had mixed-type liver injury,and 235(57.3%)had cholestasis-type liver injury.The detection rate of autoantibodies was 50.6%(212/419),and the detection rate of ANA was 42.9%(180/419),with a titer of mainly 1∶100(104/180).There was no significant difference in the detection rate of autoantibodies between the patients with different sexes(χ^(2)=2.658,P=0.103)or different types of injury(χ^(2)=0.859,P=0.651).The binary logistic regression analysis showed that autoantibody did not have a regression relationship with sex,age,and type of injury(all P>0.05)There were significant differences in prothrombin time activity(PTA)and international normalized ratio(INR)between the positive autoantibody group and the negative autoantibody group(t=2.161,P=0.031;Z=-3.010,P=0.003).The ordinal logistic regression analysis showed that INR(odds ratio[OR]=3.101,P=0.040)and IgG(OR=1.043,P=0.014)were associated with ANA grade.Conclusion There is a relatively high detection rate of autoantibodies in patients with DILI,and the detection rate of autoantibodies is not associated with sex,age,or type of injury.There are differences in PTA and INR between autoantibody-positive patients and autoantibody-negative patients,and the levels of INR and IgG are correlated with antibody titer.
作者 陈凤欣 曾湛 孙芳芳 胡蕾苹 路遥 张璐 李明慧 谢尧 CHEN Fengxin;ZENG Zhan;SUN Fangfang;HU Leiping;LU Yao;ZHANG Lu;LI Minghui;XIE Yao(Second Department of Hepatology,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,China;Second Department of Hepatology,Peking University Ditan Teaching Hospital,Beijing 100015,China)
出处 《临床肝胆病杂志》 CAS 北大核心 2022年第1期148-153,共6页 Journal of Clinical Hepatology
基金 国家科技重大专项(2018ZX10715-005-003-005) 首都临床特色专项资助项目(Z151100004015122) 北京市医管中心临床专项项目(XMLX201706,XMLX202127) 北京市医管中心消化协同中心资助项目(XXT28,XZ0302) 北京市科委课题(D161100002716002)。
关键词 药物性肝损伤 自身抗体 免疫球蛋白G Drug-Induced Liver Injury Autoantibodies Immunoglobulin G
  • 相关文献

参考文献3

二级参考文献73

  • 1Qixia Wang,Carlo Selmi,Xinmin Zhou,Dekai Qiu,Zenshan Li,Qi Miao,Xiaoyu Chen,Jianhong Wang,Edward L. Krawitt,M. Eric Gershwin,Ying Han,Xiong Ma.Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis[J].Journal of Autoimmunity.2012
  • 2Kirsten Muri Boberg,Roger W. Chapman,Gideon M. Hirschfield,Ansgar W. Lohse,Michael P. Manns,Erik Schrumpf.Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue[J].Journal of Hepatology.2010(2)
  • 3Ansgar W. Lohse,Giorgina Mieli-Vergani.Autoimmune hepatitis[J].Journal of Hepatology.2010(1)
  • 4F. Alvarez,P.A. Berg,F.B. Bianchi,L. Bianchi,A.K. Burroughs,E.L. Cancado,R.W. Chapman,W.G.E. Cooksley,A.J. Czaja,V.J. Desmet,P.T. Donaldson,A.L.W.F. Eddleston,L. Fainboim,J. Heathcote,J.-C. Homberg,J.H. Hoofnagle,S. Kakumu,E.L. Krawitt,I.R. Mackay,R.N.M. MacSween,W.C. Maddrey,M.P. Manns,I.G. McFarlane,K.-H. Meyer zum Büschenfelde,G. Mieli-Vergani,Y. Nakanuma,M. Nishioka,E. Penner,G. Porta,B.C. Portmann,W.D. Reed,J. Rodes,S.W. Schalm,P.J. Scheuer,E. Schrumpf,T. Seki,G. Toda,T. Tsuji,N. Tygstrup,D. Vergani,M. Zeniya.International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis[J].Journal of Hepatology.1999(5)
  • 5Barbara Hoeroldt,Elaine McFarlane,Asha Dube,Pandurangan Basumani,Mohammed Karajeh,Michael J. Campbell,Dermot Gleeson.Long-term Outcomes of Patients With Autoimmune Hepatitis Managed at a Nontransplant Center[J].Gastroenterology.2011(7)
  • 6M. Sui,R. Wu,X. Hu,H. Zhang,J. Jiang,Y. Yang,J. Niu.Low prevalence of hepatitis B virus infection in patients with autoimmune diseases in a Chinese patient population[J]. J Viral Hepat . 2014 (12)
  • 7J. Chen,G. D. Eslick,M. Weltman.Systematic review with meta‐analysis: clinical manifestations and management of autoimmune hepatitis in the elderly[J]. Aliment Pharmacol Ther . 2014 (2)
  • 8Lisbet Gr?nb?k,Hendrik Vilstrup,Peter Jepsen.Autoimmune hepatitis in Denmark: Incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study[J]. Journal of Hepatology . 2013
  • 9Ersan Ozaslan,Cumali Efe,Alexandra Heurgué–Berlot,Taylan Kav,Chiara Masi,Tugrul Purnak,Luigi Muratori,Yücel Ustündag,Solange Bresson–Hadni,Gérard Thiéfin,Thomas D. Schiano,Staffan Wahlin,Paolo Muratori.Factors Associated With Response to Therapy and Outcome of Patients With Primary Biliary Cirrhosis With Features of Autoimmune Hepatitis[J]. Clinical Gastroenterology and Hepatology . 2014
  • 10Kazuichi Okazaki,Kazushige Uchida,Masanori Koyabu,Hideaki Miyoshi,Tsukasa Ikeura,Makoto Takaoka.“IgG4 Cholangiopathy - current concept, diagnosis and pathogenesis “[J]. Journal of Hepatology . 2014

共引文献92

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部